Regulation

Economics / Markets

'Why Trump's healthcare reforms won't impact our 5% dividend yield'

A Q&A with BB Biotech's Head of Investment Management Daniel Koller reveals how innovation in medicine is offering investment opportunities.

clock 12 June 2017 • 1 min read

UK

CMA to investigate Standard Life Aberdeen merger

Already received approval in other countries

clock 23 May 2017 • 1 min read

Your profession

BCC calls for regulation and tax stability guarantee in election manifesto

Not all about Brexit

clock 02 May 2017 • 2 min read

Regulation

Two thirds of firms unlikely to meet MiFID II deadline

Regulatory costs expected to double in five years

clock 27 April 2017 • 2 min read

Regulation

Three areas where advisers can avoid suitability pitfalls - Rory Percival

Based on findings in FCA suitability review

clock 25 April 2017 • 3 min read

People

Richard Romer-Lee: Industry needs to ensure integrity at every turn

Responds to FCA study

clock 23 March 2017 • 7 min read

Regulation

Darius McDermott: Don't throw the baby out with the bathwater on active management

Response to FCA Study

clock 03 February 2017 • 3 min read

People

Lack of collective voice blocks industry progression, adviser warns

Industry is 'too disparate'

clock 02 February 2017 • 2 min read

Regulation

SIPP operators at risk from 'smarter scammers' - FCA

Regulator flags due diligence failings

clock 24 January 2017 • 2 min read

Regulation

Cost of regulation still biggest threat to advisers - PFS

Top of the list for the fifth year in a row

clock 23 January 2017 • 2 min read